Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez-Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O'Donnell M, McKee M, Dagenais G.

Lancet. 2019 Sep 3. pii: S0140-6736(19)32008-2. doi: 10.1016/S0140-6736(19)32008-2. [Epub ahead of print] Erratum in: Lancet. 2019 Oct 7;:.

PMID:
31492503
2.

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study.

Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, Diaz R, Avezum A, Oliveira GBF, Wielgosz A, Parambath SR, Mony P, Alhabib KF, Temizhan A, Ismail N, Chifamba J, Yeates K, Khatib R, Rahman O, Zatonska K, Kazmi K, Wei L, Zhu J, Rosengren A, Vijayakumar K, Kaur M, Mohan V, Yusufali A, Kelishadi R, Teo KK, Joseph P, Yusuf S.

Lancet. 2019 Sep 3. pii: S0140-6736(19)32007-0. doi: 10.1016/S0140-6736(19)32007-0. [Epub ahead of print] Erratum in: Lancet. 2019 Sep 6;:.

PMID:
31492501
3.

Cardiovascular Risk Assessment in Pilots.

Mulloy A, Wielgosz A.

Aerosp Med Hum Perform. 2019 Aug 1;90(8):730-734. doi: 10.3357/AMHP.5316.2019.

PMID:
31331424
4.

Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study.

Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, Avezum A, Bengtsson Boström K, Chifamba J, Gulec S, Gupta R, Igumbor EU, Iqbal R, Ismail N, Joseph P, Kaur M, Khatib R, Kruger IM, Lamelas P, Lanas F, Lear SA, Li W, Wang C, Quiang D, Wang Y, Lopez-Jaramillo P, Mohammadifard N, Mohan V, Mony PK, Poirier P, Srilatha S, Szuba A, Teo K, Wielgosz A, Yeates KE, Yusoff K, Yusuf R, Yusufali AH, Attaei MW, McKee M, Yusuf S.

Lancet Glob Health. 2019 Jun;7(6):e748-e760. doi: 10.1016/S2214-109X(19)30045-2. Epub 2019 Apr 23.

5.

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.

Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.

Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.

6.

Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.

O'Donnell M, Mente A, Rangarajan S, McQueen MJ, O'Leary N, Yin L, Liu X, Swaminathan S, Khatib R, Rosengren A, Ferguson J, Smyth A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Ismail N, Yusoff K, Dans A, Iqbal R, Szuba A, Mohammadifard N, Oguz A, Yusufali AH, Alhabib KF, Kruger IM, Yusuf R, Chifamba J, Yeates K, Dagenais G, Wielgosz A, Lear SA, Teo K, Yusuf S; PURE Investigators.

BMJ. 2019 Mar 13;364:l772. doi: 10.1136/bmj.l772.

7.

Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.

Mente A, O'Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Ah STL, Wei L, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Mony P, Szuba A, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Yusoff K, Ismail N, Gulec S, Rosengren A, Yusufali A, Kruger L, Tsolekile LP, Chifamba J, Dans A, Alhabib KF, Yeates K, Teo K, Yusuf S.

Lancet. 2018 Aug 11;392(10146):496-506. doi: 10.1016/S0140-6736(18)31376-X. Epub 2018 Aug 9.

PMID:
30129465
8.

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study.

Murphy A, Palafox B, O'Donnell O, Stuckler D, Perel P, AlHabib KF, Avezum A, Bai X, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Dans AL, Diaz R, Erbakan AN, Ismail N, Iqbal R, Kelishadi R, Khatib R, Lanas F, Lear SA, Li W, Liu J, Lopez-Jaramillo P, Mohan V, Monsef N, Mony PK, Puoane T, Rangarajan S, Rosengren A, Schutte AE, Sintaha M, Teo KK, Wielgosz A, Yeates K, Yin L, Yusoff K, Zatońska K, Yusuf S, McKee M.

Lancet Glob Health. 2018 Mar;6(3):e292-e301. doi: 10.1016/S2214-109X(18)30031-7.

9.

Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61 229 individuals in 21 countries.

Palafox B, Goryakin Y, Stuckler D, Suhrcke M, Balabanova D, Alhabib KF, Avezum A, Bahonar A, Bai X, Chifamba J, Dans AL, Diaz R, Gupta R, Iqbal R, Ismail N, Kaur M, Keskinler MV, Khatib R, Kruger A, Kruger IM, Lanas F, Lear SA, Li W, Liu J, Lopez-Jaramillo P, Peer N, Poirier P, Rahman O, Pillai RK, Rangarajan S, Rosengren A, Swaminathan S, Szuba A, Teo K, Wang Y, Wielgosz A, Yeates KE, Yusufali A, Yusuf S, McKee M.

BMJ Glob Health. 2017 Dec 17;2(4):e000443. doi: 10.1136/bmjgh-2017-000443. eCollection 2017.

10.

Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study.

Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R, Kumar R, Wentzel-Viljoen E, Rosengren A, Amma LI, Avezum A, Chifamba J, Diaz R, Khatib R, Lear S, Lopez-Jaramillo P, Liu X, Gupta R, Mohammadifard N, Gao N, Oguz A, Ramli AS, Seron P, Sun Y, Szuba A, Tsolekile L, Wielgosz A, Yusuf R, Hussein Yusufali A, Teo KK, Rangarajan S, Dagenais G, Bangdiwala SI, Islam S, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet. 2017 Nov 4;390(10107):2050-2062. doi: 10.1016/S0140-6736(17)32252-3. Epub 2017 Aug 29.

PMID:
28864332
11.

Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study.

Miller V, Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G, Gupta R, Mohan V, Lear S, Bangdiwala SI, Schutte AE, Wentzel-Viljoen E, Avezum A, Altuntas Y, Yusoff K, Ismail N, Peer N, Chifamba J, Diaz R, Rahman O, Mohammadifard N, Lana F, Zatonska K, Wielgosz A, Yusufali A, Iqbal R, Lopez-Jaramillo P, Khatib R, Rosengren A, Kutty VR, Li W, Liu J, Liu X, Yin L, Teo K, Anand S, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet. 2017 Nov 4;390(10107):2037-2049. doi: 10.1016/S0140-6736(17)32253-5. Epub 2017 Aug 29.

12.

Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study.

Mente A, Dehghan M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A, Lear S, Li W, Chen H, Yi S, Wang Y, Diaz R, Avezum A, Lopez-Jaramillo P, Seron P, Kumar R, Gupta R, Mohan V, Swaminathan S, Kutty R, Zatonska K, Iqbal R, Yusuf R, Mohammadifard N, Khatib R, Nasir NM, Ismail N, Oguz A, Rosengren A, Yusufali A, Wentzel-Viljoen E, Puoane T, Chifamba J, Teo K, Anand SS, Yusuf S; Prospective Urban Rural Epidemiology (PURE) study investigators.

Lancet Diabetes Endocrinol. 2017 Oct;5(10):774-787. doi: 10.1016/S2213-8587(17)30283-8. Epub 2017 Aug 29.

PMID:
28864143
13.

Comorbid Conditions in Canadians Hospitalized Because of Diabetes.

Wielgosz A, Dai S, Walsh P, McCrea-Logie J, Celebican E.

Can J Diabetes. 2018 Feb;42(1):106-111. doi: 10.1016/j.jcjd.2017.03.004. Epub 2017 May 31. Review.

PMID:
28579199
14.

Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries.

Palafox B, McKee M, Balabanova D, AlHabib KF, Avezum AJ, Bahonar A, Ismail N, Chifamba J, Chow CK, Corsi DJ, Dagenais GR, Diaz R, Gupta R, Iqbal R, Kaur M, Khatib R, Kruger A, Kruger IM, Lanas F, Lopez-Jaramillo P, Minfan F, Mohan V, Mony PK, Oguz A, Palileo-Villanueva LM, Perel P, Poirier P, Rangarajan S, Rensheng L, Rosengren A, Soman B, Stuckler D, Subramanian SV, Teo K, Tsolekile LP, Wielgosz A, Yaguang P, Yeates K, Yongzhen M, Yusoff K, Yusuf R, Yusufali A, Zatońska K, Yusuf S.

Int J Equity Health. 2016 Dec 8;15(1):199.

15.

The Impact of Using Different Methods to Assess Completeness of 24-Hour Urine Collection on Estimating Dietary Sodium.

Wielgosz A, Robinson C, Mao Y, Jiang Y, Campbell NR, Muthuri S, Morrison H.

J Clin Hypertens (Greenwich). 2016 Jun;18(6):581-4. doi: 10.1111/jch.12716. Epub 2015 Oct 12.

16.

Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection.

Mente A, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, Zeidler J, Fu L, DeJesus J, Rangarajan S, Bourlaud AS, De Bluts AL, Corber E, de Jong V, Boomgaardt J, Shane A, Jiang Y, de Groh M, O'Donnell MJ, Yusuf S, Teo K.

Can J Cardiol. 2016 Mar;32(3):319-26. doi: 10.1016/j.cjca.2015.06.020. Epub 2015 Jun 25.

PMID:
26454468
17.

Early cerebral small vessel disease and brain volume, cognition, and gait.

Smith EE, O'Donnell M, Dagenais G, Lear SA, Wielgosz A, Sharma M, Poirier P, Stotts G, Black SE, Strother S, Noseworthy MD, Benavente O, Modi J, Goyal M, Batool S, Sanchez K, Hill V, McCreary CR, Frayne R, Islam S, DeJesus J, Rangarajan S, Teo K, Yusuf S; PURE Investigators.

Ann Neurol. 2015 Feb;77(2):251-61. doi: 10.1002/ana.24320.

18.

A robust method for iodine status determination in epidemiological studies by capillary electrophoresis.

de Macedo AN, Teo K, Mente A, McQueen MJ, Zeidler J, Poirier P, Lear SA, Wielgosz A, Britz-McKibbin P.

Anal Chem. 2014 Oct 21;86(20):10010-5. doi: 10.1021/ac503231u. Epub 2014 Oct 8.

PMID:
25280130
19.

Cardiovascular risk and events in 17 low-, middle-, and high-income countries.

Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L, Zhang S, Mony P, Swaminathan S, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear S, Anand S, Wielgosz A, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Iqbal R, Rahman O, Rosengren A, Yusufali A, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Oguz A, McQueen M, McKee M, Dagenais G; PURE Investigators.

N Engl J Med. 2014 Aug 28;371(9):818-27. doi: 10.1056/NEJMoa1311890.

20.

Association of urinary sodium and potassium excretion with blood pressure.

Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, Morrison H, Li W, Wang X, Di C, Mony P, Devanath A, Rosengren A, Oguz A, Zatonska K, Yusufali AH, Lopez-Jaramillo P, Avezum A, Ismail N, Lanas F, Puoane T, Diaz R, Kelishadi R, Iqbal R, Yusuf R, Chifamba J, Khatib R, Teo K, Yusuf S; PURE Investigators.

N Engl J Med. 2014 Aug 14;371(7):601-11. doi: 10.1056/NEJMoa1311989.

21.

Incidental magnetic resonance diffusion-weighted imaging-positive lesions are rare in neurologically asymptomatic community-dwelling adults.

Batool S, O'Donnell M, Sharma M, Islam S, Dagenais GR, Poirier P, Lear SA, Wielgosz A, Teo K, Stotts G, McCreary CR, Frayne R, DeJesus J, Rangarajan S, Yusuf S, Smith EE; PURE Study Investigators.

Stroke. 2014 Jul;45(7):2115-7. doi: 10.1161/STROKEAHA.114.005782. Epub 2014 Jun 12.

PMID:
24923720
22.

Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries.

Mente A, O'Donnell MJ, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, Jiang Y, Xingyu W, Jian B, Calik KB, Akalin AA, Mony P, Devanath A, Yusufali AH, Lopez-Jaramillo P, Avezum A Jr, Yusoff K, Rosengren A, Kruger L, Orlandini A, Rangarajan S, Teo K, Yusuf S.

J Hypertens. 2014 May;32(5):1005-14; discussion 1015. doi: 10.1097/HJH.0000000000000122.

PMID:
24569420
23.

Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators.

JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.

24.

Outcomes among 3.5 million newly diagnosed hypertensive Canadians.

Quan H, Chen G, Tu K, Bartlett G, Butt DA, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, Khan N, Lix LM, Smith M, Svenson L, Walker RL, Wielgosz A, McAlister FA; Hypertension Outcome and Surveillance Team.

Can J Cardiol. 2013 May;29(5):592-7. doi: 10.1016/j.cjca.2012.12.016. Epub 2013 Mar 5.

PMID:
23465341
25.

Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity.

Quan H, Chen G, Walker RL, Wielgosz A, Dai S, Tu K, Campbell NR, Hemmelgarn BR, Hill MD, Johansen H, McAlister FA, Khan N; Hypertension Outcome and Surveillance Team.

Heart. 2013 May;99(10):715-21. doi: 10.1136/heartjnl-2012-303152. Epub 2013 Feb 12.

PMID:
23403406
26.

Comorbidities and mortality associated with hospitalized heart failure in Canada.

Dai S, Walsh P, Wielgosz A, Gurevich Y, Bancej C, Morrison H.

Can J Cardiol. 2012 Jan-Feb;28(1):74-9. doi: 10.1016/j.cjca.2011.05.002. Epub 2011 Aug 31.

PMID:
21885240
27.

Non-communicable diseases--finally on the global agenda.

Wielgosz AT.

Chronic Dis Inj Can. 2011 Jun;31(3):95-6.

28.

Motivational counselling for physical activity in patients with coronary artery disease not participating in cardiac rehabilitation.

Reid RD, Morrin LI, Higginson LA, Wielgosz A, Blanchard C, Beaton LJ, Nelson C, McDonnell L, Oldridge N, Wells GA, Pipe AL.

Eur J Prev Cardiol. 2012 Apr;19(2):161-6. doi: 10.1177/1741826711400519. Epub 2011 Feb 21.

PMID:
21450579
29.

The incidence of cancer in a population-based cohort of Canadian heart transplant recipients.

Jiang Y, Villeneuve PJ, Wielgosz A, Schaubel DE, Fenton SS, Mao Y.

Am J Transplant. 2010 Mar;10(3):637-45. doi: 10.1111/j.1600-6143.2009.02973.x. Epub 2010 Feb 1.

30.

Strengthening information systems for heart health in Canada.

McFarlane A, Wielgosz A; Canadian Heart Health Strategy and Action Plan Theme Working Group 1.

Can J Cardiol. 2009 Nov;25(11):631-4. Review.

31.

Socioeconomic status and cardiovascular disease: risks and implications for care.

Clark AM, DesMeules M, Luo W, Duncan AS, Wielgosz A.

Nat Rev Cardiol. 2009 Nov;6(11):712-22. doi: 10.1038/nrcardio.2009.163. Epub 2009 Sep 22. Review.

PMID:
19770848
32.

Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.

Campbell NR, Brant R, Johansen H, Walker RL, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force.

Hypertension. 2009 Feb;53(2):128-34. doi: 10.1161/HYPERTENSIONAHA.108.119784. Epub 2008 Dec 29.

PMID:
19114646
33.

A clinical decision rule to identify which chest pain patients can safely be removed from cardiac monitoring in the emergency department.

Gatien M, Perry JJ, Stiell IG, Wielgosz A, Lee JS.

Ann Emerg Med. 2007 Aug;50(2):136-43. Epub 2007 May 11.

PMID:
17498844
34.

A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer.

Paszat LF, Vallis KA, Benk VM, Groome PA, Mackillop WJ, Wielgosz A.

Radiother Oncol. 2007 Mar;82(3):294-300. Epub 2007 Feb 5.

PMID:
17276533
35.

Determinants of physical activity after hospitalization for coronary artery disease: the Tracking Exercise After Cardiac Hospitalization (TEACH) Study.

Reid RD, Morrin LI, Pipe AL, Dafoe WA, Higginson LA, Wielgosz AT, LeHaye SA, McDonald PW, Plotnikoff RC, Courneya KS, Oldridge NB, Beaton LJ, Papadakis S, Slovinec D'Angelo ME, Tulloch HE, Blanchard CM.

Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):529-37. Erratum in: Eur J Cardiovasc Prev Rehabil. 2008 Dec;15(6):747. LaHaye, Stephen A [added].

PMID:
16874141
36.

Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada.

Johansen HL, Wielgosz AT, Nguyen K, Fry RN.

Can J Cardiol. 2006 Jan;22(1):65-71.

37.

Use of medical counseling for the prevention and control of smoking in the municipality of old Havana.

Varona P, Bonet M, Fernandez N, Canizares M, Roche RG, Ibarra AM, Wielgosz A.

J Urban Health. 2005 Mar;82(1):71-5. Epub 2005 Feb 28.

38.

Diagnostic performance of venous lactate on arrival at the emergency department for myocardial infarction.

Gatien M, Stiell I, Wielgosz A, Ooi D, Lee JS.

Acad Emerg Med. 2005 Feb;12(2):106-13.

39.

Assessment of the cardiac patient for fitness to fly: flying subgroup executive summary.

Ross D, Essebag V, Sestier F, Soder C, Thibeault C, Tyrrell M, Wielgosz A; Canadian Cardiovascular Society Consensus Conference.

Can J Cardiol. 2004 Nov;20(13):1321-3. No abstract available.

PMID:
15565194
40.

Information and communication technology in cardiovascular disease prevention in developing countries: hype and hope. Report of the International Collaboration on Information Use in Cardiovascular Health Promotion in Developing Countries.

Jabbour S, Nishtar S, Prabhakaran D, Chockalingam A, Achutti A, Agrawal A, Luna MA, Garofalo F, Wielgosz A; International Collaboration on Information Use in Cardiovascular Health Promotion in Developing Countries.

Int J Cardiol. 2003 Dec;92(2-3):105-11.

PMID:
14659841
41.

Surveillance at work: zeroing in on cardiovascular diseases in regional health units across Canada.

Wielgosz A.

Can J Cardiol. 2003 Oct;19(11):1239-40. No abstract available.

PMID:
14571308
42.

Incident cerebrovascular disease in rural and urban Alberta.

Yiannakoulias N, Svenson LW, Hill MD, Schopflocher DP, Rowe BH, James RC, Wielgosz AT, Noseworthy TW.

Cerebrovasc Dis. 2004;17(1):72-8. Epub 2003 Oct 6.

PMID:
14534379
43.

Regional comparisons of inpatient and outpatient patterns of cerebrovascular disease diagnosis in the province of Alberta.

Yiannakoulias N, Svenson LW, Hill MD, Schopflocher DP, James RC, Wielgosz AT, Noseworthy TW.

Chronic Dis Can. 2003 Winter;24(1):9-16.

PMID:
12757631
44.

CCORT/CCS quality indicators for acute myocardial infarction care.

Tran CT, Lee DS, Flintoft VF, Higginson L, Grant FC, Tu JV, Cox J, Holder D, Jackevicius C, Pilote L, Tanser P, Thompson C, Tsoi E, Warnica W, Wielgosz A; Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society; Acute Myocardial Infarction Quality Indicator Panel.

Can J Cardiol. 2003 Jan;19(1):38-45.

PMID:
12571693
45.

Hormone replacement therapy and cardiovascular disease.

Abramson B, Derzko C, Lalonde A, Reid R, Turek M, Wielgosz A.

J Obstet Gynaecol Can. 2002 Jul;24(7):577-82. Review. English, French. No abstract available.

PMID:
12196851
46.

Hormone replacement therapy and cardiovascular disease: a joint statement.

Abramson B, Derzko C, Lalonde A, Reid R, Turek M, Wielgosz A; Canadian Cardiovascular Society; Society of Obstetricians and Gynaecologists of Canada; Heart and Stroke Foundation of Canada.

Can J Cardiol. 2002 Jul;18(7):723-4. No abstract available.

PMID:
12167958
47.

Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer.

Vallis KA, Pintilie M, Chong N, Holowaty E, Douglas PS, Kirkbride P, Wielgosz A.

J Clin Oncol. 2002 Feb 15;20(4):1036-42.

PMID:
11844827
48.

Cardiovascular risk factors in supersonic pilots in Poland.

Mazurek K, Wielgosz A, Efenberg B, Orzel A.

Aviat Space Environ Med. 2000 Dec;71(12):1202-5.

PMID:
11439719
49.

[Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].

Rutkowski B, Wielgosz A, Manitius J, Bułło B, Kowalewska J, Tylicki L, Roszkiewicz A.

Przegl Lek. 2000;57(11):624-7. Polish.

PMID:
11293209
50.

Living with heart disease: the 2001 Annual Report Card on the Health of Canadians.

Wielgosz A; Heart and Stroke Foundation of Canada.

Can J Cardiol. 2001 Feb;17(2):148-9. Review. No abstract available.

PMID:
11223483

Supplemental Content

Loading ...
Support Center